See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday. More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.

Chemical Class · Analytical Standards

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
10007975 (±)11,12-DHET-d11 Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2008-03-17 13.530276243094 -11-12-dhet-d11 (±)11,12-DiHETrE-d11 epoxides epoxygenases DHT hydrolases (+/-)11,12-DiHETrEs deuterated epoxide hydrolase deuterated deuterium 13.530276243094
10006413 11(12)-EET-d11 Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2008-03-25 32.847163904235 11-12-eet-d11 11(12)-EpETrE-d11 epoxides epoxygenases 11,12-EETs cytochrome P450 (+/-)11,12-EpETrEs (+/-)11(12)-EpETrEs deuterated deuterium 32.847163904235
319500 11-dehydro Thromboxane B2-d4 - ≥99% deuterated forms (d1-d4) 41.575980662983 11-dehydro-thromboxane-b2-d4 11-keto TXB2-d4 GC/MS deuterium isotopes 11-dh-TXB2-d4 internal standards thromboxanes 11-dehydro-TXB2-d4 deuterated GC-MS LC/MS LC-MS mass spectrometry atherosclerosis 41.575980662983
10006831 11-dehydro Thromboxane B2 Quant-PAK - 2005-08-08 25.818526703499 11-dehydro-thromboxane-b2-quant-pak Quant-PAKs metabolites thromboxanes plasma deuterium isotopes 11-dh-TXB2-d4 internal standards 11-dehydro-TXB2-d4 deuterated GC/MS GC-MS LC/MS LC-MS mass spectrometry atherosclerosis packs 25.818526703499
10009898 (−)-11-nor-9-carboxy-Δ9-THC-d3 (solution) 130381-15-6 ≥99% deuterated forms (d1-d3) 2010-11-12 8.249654696132 -11-nor-9-carboxy-9-thc-d3-solution THC metabolites Delta9-THC Δ9 THC tetrahydrocannabinols marijuana deuterateds deuterium internal standards mass spectrometry GC/MS LC/MS GC-MS LC-MS MS cannabinoids cbs synthetic 10916 8.249654696132
10007246 11(S)-HETE Lipid Maps MS Standard 54886-50-9 ≥98% 2009-02-17 4.907196132596 11-s-hete-lipid-maps-ms-standard hydroxy fatty acids 11-HETEs 11S-HETEs 11(S)-HETEs 11(S)HETEs 11-LOs 11-lipoxygenases MS mass spectrometry standards 4.907196132596
10009994 (±)12,13-DiHOME-d4 - ≥99% deuterated forms (d1-d4) 2007-06-26 4.188692449355 -12-13-dihome-d4 Isoleukotoxin diol-d4 epoxides epoxygenase leukotoxin cytochrome P450 CYP450 sEH soluble epoxide hydrolase UGT glucuronidation UGT2B7 mass spectrometry MS deuterated deuterium 4.188692449355
10009996 12(13)-EpOME-d4 - ≥99% deuterated forms (d1-d4) 2007-06-04 3.260718232043 12-13-epome-d4 iso-Leukotoxin-d4; 12,13-EODE-d4 epoxides epoxygenases cytochrome P450 (+/-)12,13-EpOMEs (+/-)12(13)-EpOMEs epoxy fatty acids 3.260718232043
334570 12(S)-HETE-d8 84807-90-9 ≥99% deuterated forms (d1-d8) 39.844961325967 12-s-hete-d8 GC/MS deuterium isotopes 12-HETE-d8 standards12S-HETE-d8 deuterated GC-MS LC/MS LC-MS 12-HETEs 12(S)-HETEs 12S-HETEs 12(S)HETEs hydroxy fatty acids 12(S)HETE-d8 mass spectrometry 39.844961325967
10007793 13,14-dihydro-15-keto Prostaglandin F2α-d4 - ≥99% deuterated forms (d1-d4) 2006-02-06 16.382958312406 13-14-dihydro-15-keto-prostaglandin-f2-d4 PGFM-d4 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry 13,14-dihydro-15-keto-PGF2a 13,14-dihydro-15-keto-PGF2.alpha. metabolites prostaglandins 16.382958312406
10007226 13,14-dihydro-15-keto Prostaglandin F2α Lipid Maps MS Standard 27376-76-7 >99% 2008-12-04 4.260740331491 13-14-dihydro-15-keto-prostaglandin-f2-lipid-maps-ms-standard 13,14-dihydro-15-keto PGF2α; PGFM; 13,14-dh-15-k PGF2α 13,14-dihydro-15-keto-PGF2alpha 13,14-dihydro-15-keto-PGF2.alpha. metabolites prostaglandins MS mass spectrometry PGs marker plasma 4.260740331491
9000281 13,14-dihydro Prostaglandin E1-d4 - ≥99% deuterated forms (d1-d4) 2004-05-06 41.217624309392 13-14-dihydro-prostaglandin-e1-d4 13,14-dh PGE1-d4; Prostaglandin E0-D4 PGE0 metabolites 13,14-dihydro-PGE1 prostaglandins GC/MS deuterium isotopes PGA2-d4 internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry gas liquid chromatography spectroscopy 41.217624309392
338620 13-OxoODE-d3 - ≥99% deuterated forms (d1-d3) 2011-11-11 7.245543278085 13-oxoode-d3 13-KODE-d3 13-KODEs fatty metabolites 13-OxoODEs 13-oxo-ODEs oxo-acids deuterateds deuterium mass spectrometry LC-MS LC/MS NAD+ rats colonic cells proliferation oxo-fatty 13-HODEs HODEs NAD dependent dehydrogenase mucosa intra-rectally intrarectally maturation reticulocytes erythrocytes 15-LO 15-lipoxygenase OxoODEs 7.245543278085
338610 13(S)-HODE-d4 139408-39-2 ≥99% deuterated forms (d1-d4) 38.766077348066 13-s-hode-d4 GC/MS deuterium isotopes 13-HODE-d4 standards 13S-HODE-d4 deuterated GC-MS LC/MS LC-MS 13-HODEs 13(S)-HODEs 13S-HODEs 13(S)HODEs hydroxy fatty acids 13(S)HODE-d4 mass spectrometry 38.766077348066
10008040 (±)14,15-DHET-d11 Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2008-03-18 29.655414364641 -14-15-dhet-d11 (±)14,15-DiHETrE-d11 epoxides epoxygenases DHT hydrolases (+/-)14,15-DiHETrEs deuterated epoxide hydrolase deuterium 29.655414364641
10007267 (±)14,15-DHET Lipid Maps MS Standard - >98% 2009-01-06 27.189834254144 -14-15-dhet-lipid-maps-ms-standard (±)14,15-DiHETrE epoxides epoxygenases DHTs hydrolases (+/-)14,15-DiHETrEs MS mass spectrometry standards 27.189834254144
10006410 14(15)-EET-d11 - ≥99% deuterated forms (d1-d11) 2007-07-22 91.322375690608 14-15-eet-d11 14(15)-EpETrE-d11 epoxides epoxygenases cytochrome P450 (+/-)14(15)-EpETrEs (+/-)5,6-EpETrEs fatty acids deuterated deuterium CYP450 mass spectrometry MS 14,15-EETs biosynthesized liver microsomes pregnancy hypertension 91.322375690608
318570 15-deoxy-Δ12,14-Prostaglandin J2-d4 - ≥99% deuterated forms (d1-d4) 30.284861878453 15-deoxy-12-14-prostaglandin-j2-d4 15-deoxy-Δ12,14-PGJ2-d4 GC/MS deuterium isotopes 15-deoxy-DELTA12,14-PGJ2-d4 15-deoxy-.DELTA.12,14-PGJ2-d4 15-deoxy-D12,14-PGJ2-d4 internal standards prostaglandins deuterated mass spectrometry GC-MS LC-MS LC/MS atherosclerosis 30.284861878453
334720 15(S)-HETE-d8 84807-87-4 ≥99% deuterated forms (d1-d8) 33.119594843463 15-s-hete-d8 GC/MS deuterium isotopes 15-HETE-d8 standards 15S-HETE-d8 15(S)HETE-d8 deuterated GC-MS LC/MS LC-MS 15-HETEs 15(S)-HETEs 15S-HETEs 15(S)HETEs hydroxy fatty acids mass spectrometry 15HETE 33.119594843463
10007259 15(S)-HpETE Lipid Maps MS Standard 70981-96-3 >98% 2009-02-10 9.112486187845 15-s-hpete-lipid-maps-ms-standard 15-LOs 15-HpETEs 15S-HpETEs hydroperoxides 15(S)-HpETEs 15(S)HPETEs 15-lipoxygenases monohydroperoxy fatty arachidonic acids polyunsaturated MS mass spectrometry standards 9.112486187845
316810 17-phenyl trinor Prostaglandin F2α-d4 - ≥99% deuterated forms (d1-d4) 30.387140883977 17-phenyl-trinor-prostaglandin-f2-d4 17-phenyl trinor PGF2α-d4; Bimatoprost (free acid)-d4 GC/MS deuterium isotopes 17-phenyl-trinor-PGF2.alpha.-3,3,4,4-d4 17-pheny-trinor-PGF2alpha-3,3,4,4-d4 GC-MS LS/MS LC-MS mass spectrometry spectroscopy chromatography deuterateds 30.387140883977
316820 17-phenyl trinor Prostaglandin F2α ethyl amide-d4 - ≥99% deuterated forms (d1-d4) 53.555298844801 17-phenyl-trinor-prostaglandin-f2-ethyl-amide-d4 17-phenyl trinor PGF2α ethyl amide-d4; Bimatoprost-d4 GC/MS deuterium isotopes 8-isoprostanes 17-phenyl-trinor-PGF2.alpha.-3,3,4,4-d4 17-phenyl-trinor-PGF2alpha-3,3,4,4-d4 GC-MS LS/MS LC-MS mass spectrometry spectroscopy chromatography deuterateds 53.555298844801
362152 1-Arachidonoyl Glycerol-d5 - ≥99% deuterated forms (d1-d5) 36.490704419889 1-arachidonoyl-glycerol-d5 1-AG-d5 deuterium isotopes GC/MS endocannabinoids anandamides 1AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 1-AG-d5 internal fatty acids cannabinoids cbs synthetic 36.490704419889
390030 20-HETE-d6 - ≥99% deuterated forms (d1-d6) 94.095276243094 20-hete-d6 20-hydroxy Arachidonic Acid-d6 CYP450 vasocontriction standards vasoconstrictors GC-MS GC/MS LC-MS LC/MS cytochrome chromatography mass spectroscopy deuterium deuterateds 94.095276243094
10007269 20-HETE Lipid Maps MS Standard 79551-86-3 ≥98% 2009-02-18 22.238900552486 20-hete-lipid-maps-ms-standard 20-hydroxy Arachidonic Acid hydroxy fatty acids omega-oxidation .omega.-oxidation w-oxidation cytochrome P450 CYP450 arachidonic HETEs metabolites P-450 vasoconstrictors vasoconstriction MS mass spectrometry standards 22.238900552486
10007225 2,3-dinor-11β-Prostaglandin F2α Lipid Maps MS Standard 240405-20-3 >98% 2008-12-17 67.957988950276 2-3-dinor-11-prostaglandin-f2-lipid-maps-ms-standard 2,3-dinor-11β-PGF2α 2,3-dinor-11.beta.-PGF2.alpha. 2,3-dinor-11beta-PGF2alpha 2,3-dinor-11b-PGF2alpha prostaglandins urine PGD2 asthmatic asthma urinary PGs 2,3-dinor-11β-PGF2α MS mass spectrometry standards 67.957988950276
11099 25-hydroxy Cholesterol-d6 New 88247-69-2 ≥99% deuterated forms (d1-d6) 2012-01-27 0.241974626560 25-hydroxy-cholesterol-d6 deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 16505-96-7 oxysterol cholesterol SREBP sterols regulatory elements binding proteins atherosclerosis anticancer apoptosis immunosuppressive Bcl-2 caspases atherosclerosis antitumor tumors LXR-RXR ligands T cells macrophages 0.241974626560
362162 2-Arachidonoyl Glycerol-d5 - ≥99% deuterated forms (d1-d5) 47.930980662983 2-arachidonoyl-glycerol-d5 2-AG-d5 deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 2-AG-d5 internal fatty acids lipids neurochemistry neuroscience endocrinology cannabinoids cbs synthetic 47.930980662983
362160 2-Arachidonoyl Glycerol-d8 - ≥99% deuterated forms (d1-d8) 84.020801104972 2-arachidonoyl-glycerol-d8 2-AG-d8 deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d8 GC-MS mass spectrometry LC/MS LC-MS deuterated standards internal neurochemistry neuroscience endocrinology cannabinoids cbs synthetic 84.020801104972
10918 (±)3-epi CP 47,497-C8-homolog - ≥98% 2011-05-06 9.598423751790 -3-epi-cp-47-497-c8-homolog (±)-trans-CAY10596 (±)-3-epi CP 47,497-C8 analogs trans-CAY10596 cannabinoids analogs receptors by-product standards (+)-CP 47,497-C8 CB2 CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 13802 9.598423751790
13802 (±)3-epi CP 47,497-C8-homolog (solution) Exclusive - ≥98% ✓ 2010-08-04 9.270452402875 -3-epi-cp-47-497-c8-homolog-solution (±)-trans-CAY10596 (±)-3-epi CP 47,497-C8 analogs trans-CAY10596 cannabinoids analogs receptors by-product standards (+)-CP 47,497-C8 CB2 CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 10918 9.270452402875
10730 3-Fluoromethcathinone (hydrochloride) - ≥98% 2011-04-26 51.741855430261 3-fluoromethcathinone-hydrochloride 3-FMC flephedrones cathinones analogs designer drugs plant feeders forensic analysis CMF-3 1049677-77-1 51.741855430261
10859 4-Fluoromethcathinone (hydrochloride) 7589-35-7 ≥98% 2011-05-31 55.123920806166 4-fluoromethcathinone-hydrochloride 4-FMC; Flephedrone flephedrones 4-FMC cathionones analogs 4 FMC 4FMC derivatives drugs plants feeders forensics 447-40-5 4-fluoroephedrone hcl 55.123920806166
332101 4-hydroxy Nonenal-d3 - ≥99% deuterated forms (d1-d3) 2004-01-28 41.869250197316 4-hydroxy-nonenal-d3 4-HNE-d3 ROS alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species 4-OH-nonenal 4-hydroxynonenal deuterium deuterateds 41.869250197316
9000876 4-hydroxy Nonenal Glutathione-d3 Exclusive - ≥99% deuterated forms (d1-d3) ✓ 2010-10-29 9.519444444444 4-hydroxy-nonenal-glutathione-d3 4-HNE-GSH-d3 oxidative stress lipids peroxidation 4-hydroxy nonenal 4-HNE deuterateds GSH-HNE internal standards mass spectrometry HNE-GSH-d3 deuteriums GC/MS LC/MS LC-MS MS 9.519444444444
10801 4-Methylmethcathinone (hydrochloride) 1189726-22-4 ≥98% 2011-06-17 36.971516916490 4-methylmethcathinone-hydrochloride 4-MMC; 4-Methylephedrone; Mephedrone designer drugs methcathinone cathinones methamphetamine bath salts plants food feeder forensics psychoactive analysis hallucinogen meow bounce bubbles mad cow 4MMC MMC methylephedrone 1189805-46-6 4-methyl-methcathinone 36.971516916490
10004174 4-oxo 2-Nonenal-d3 Exclusive - ≥99% deuterated forms (d1-d3) ✓ 2004-03-10 32.266666666666 4-oxo-2-nonenal-d3 4-ONE-d3 ROS Alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species 4-OH-2-nonenal-d3 4-hydroxy2nonenald3 internal standards mass spectrometry GC/MS LC/MS gc-ms ic-ms deuterium deuterateds 32.266666666666
10009984 5(6)-EET-d11 - ≥99% deuterated forms (d1-d11) 2007-06-06 15.434309392266 5-6-eet-d11 5(6)-EpETrE-d11 epoxides epoxygenases cytochrome P450 (+/-)5(6)-EpETrEs (+/-)5,6-EpETrEs 5,6-EETs fatty acids deuterated deuterium 15.434309392266
13803 (±)5-epi CP 55,940 - ≥98% 2010-08-04 8.949804118533 -5-epi-cp-55-940 (±)-5-trans-CP 55,940 (±)-CP 55,940 cannabinoids analogs receptors pains analgesics by-products standards Δ9-THC delta-tetrahydrocannabidiol CP 55940 CP44950 CP-55940 CP55,940 8.949804118533
10006654 5-iPF2α-VI-d11 - ≥99% deuterated forms (d1-d11) 2005-03-17 122.834497237569 5-ipf2-vi-d11 isoprostanes peroxidation oxidative injury deuterateds deuteriums isotopes 8,12-isoprostanes iPF2alpha-VI-d11 prostaglandins iPF2a-VI-d11 urine peroxidative damage enantiomers stress 122.834497237569
334250 5-OxoETE-d7 - ≥99% deuterated forms (d1-d7) 21.702707182320 5-oxoete-d7 5-KETE-d7 GC/MS deuterium isotopes 5-KETEs oxo-acids 5oxoetes 5ketes 5-oxo-ete-d7 standards fatty LC/MS GC-MS LC-MS mass spectrometry deuterated 5-oxoETEs 21.702707182320
10007737 5(S),6(R)-Lipoxin A4-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2009-04-09 43.384917127072 5-s-6-r-lipoxin-a4-d5 5(S),6(R)-LXA4-d5; 5(S),6(R),15(S)-TriHETE-d5 LXA4 lipoxins trihydroxy fatty acids leukocytes activation deuterated deuteriums MS LC mass spectrometry standards GC 43.384917127072
10007271 5(S),6(R)-Lipoxin A4 Lipid Maps MS Standard 89663-86-5 ≥95% 2009-02-18 37.582744014733 5-s-6-r-lipoxin-a4-lipid-maps-ms-standard 5(S),6(R),15(S)-TriHETE; 5(S),6(R)-LXA4 LXA4 lipoxins trihydroxy fatty acids leukocytes activation MS mass spectrometry standards 37.582744014733
10007253 5(S),6(S)-DiHETE Lipid Maps MS Standard 82948-87-6 ≥98% 2009-02-17 2.406058931860 5-s-6-s-dihete-lipid-maps-ms-standard LTA4 hydrolysis DHT 5S,6S-DiHETEs 5(S),6(S)-DiHETEs 5,6-DiHETEs MS mass spectrometry standards 2.406058931860
334230 5(S)-HETE-d8 330796-62-8 ≥99% deuterated forms (d1-d8) 25.102223756906 5-s-hete-d8 GC/MS deuterium isotopes 5-HETEs 5S-HETEs standards hydroxy fatty acids LC/MS GC-MS LC-MS mass spectrometry 5-HETE-d8 5S-HETE-d8 5(S)-HETEs deuterated 5(S)HETES 5(S)HETE-d8 25.102223756906
10007276 5(S)-HETE-d8 Lipid Maps MS Standard - ≥99% deuterated product 2009-02-26 22.268632596685 5-s-hete-d8-lipid-maps-ms-standard GC/MS deuterium isotopes 5-HETEs 5S-HETEs standards hydroxy fatty acids LC/MS GC-MS LC-MS mass spectrometry 5-HETE-d8 5S-HETE-d8 5(S)-HETEs deuterated 5(S)HETES 5(S)HETE-d8 22.268632596685
10007243 5(S)-HETE Lipid Maps MS Standard 70608-72-9 >98% 2009-01-06 21.821860036832 5-s-hete-lipid-maps-ms-standard arachidonic 5-lipoxygenases 5-LOs hydroxy acids 5S-HETEs 5-HETEs 5(S)-HETEs 5(S)HETEs fatty MS mass spectrometry standards 21.821860036832
10742 5(Z),8(Z),11(Z)-Eicosatrienoic Acid-d6 Exclusive - ≥99% deuterated forms (d1-d6) ✓ 2011-06-28 2.530957642725 5-z-8-z-11-z-eicosatrienoic-acid-d6 Mead Acid-d6 standards GC-MS GC/MS LC-MS LC/MS mass spectroscopy deuterium deuterateds fatty acids deficient PUFAs omega-3 omega-6 omega 6 omega 3 polyunsaturated ω-3 ω-6 ω3 ω6 ω 3 ω 6 2.530957642725
9000215 5(Z),8(Z),11(Z)-Eicosatrienoic Acid methyl ester - ≥98% 2010-11-29 10.848121546961 5-z-8-z-11-z-eicosatrienoic-acid-methyl-ester Mead Acid methyl ester polyunsaturated fatty acids PUFAs essential deficiency standards 20:3 (n-9) methyl ester 10.848121546961
315210 6-keto Prostaglandin F1α-d4 - ≥99% deuterated forms (d1-d4) 19.680176795580 6-keto-prostaglandin-f1-d4 6-keto PGF1α-d4 GC/MS deuterium isotopes 6-keto-PGF1a-d4 6-keto-PGF1alpha-d4 6-keto-PGF1.alpha.-d4 internal standards prostaglandins PGFα deuterated LC/MS GC-MS LC-MS mass spectrometry d4 atherosclerosis 19.680176795580
10009998 (±)8,9-DHET-d11 Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2008-03-17 10.037569060774 -8-9-dhet-d11 (±)8,9-DiHETrE-d11 epoxides epoxygenases DHT hydrolases (+/-)14,15-DiHETrEs deuterated epoxide hydrolase deuterated deuterium 10.037569060774
10009532 8(9)-EET-d11 - ≥99% deuterated forms (d1-d11) 2008-03-25 11.298416206261 8-9-eet-d11 8(9)-EpETrE-d11 epoxides epoxygenases cytochrome P450 (±)8,9-EpETrEs (+/-)8,9-EpETrEs fatty acids (+/-)8(9)EpETrEs 8(9)EETs eicosatrienoic 8,9-EETs deuterated racemic mixture 11.298416206261
316350 8-iso Prostaglandin F2α-d4 211105-40-7 ≥99% deuterated forms (d1- d4) 101.686063535911 8-iso-prostaglandin-f2-d4 15-F2t-Isoprostane-d4; iPF2α-III-d4; 8-epi PGF2α-d4; 8-Isoprostane-d4 GC/MS deuterium isotopes 8-isoprostanes 8-epi-PGF2.alpha.-d4 8-epi-PGF2alpha-d4 8-iso-PGF2.alpha.-d4 8-iso-PGF2alpha-d4 internal standards prostaglandins mass spectrometry LC/MS GC-MS LC-MS deuterated 8-iso-PGF2a-d4 8-epi-PGF2a-d4 ipf2a neurochemistry 316351 101.686063535911
10009995 9(10)-EpOME-d4 - ≥99% deuterated forms (d1-d4) 2007-06-01 3.026095764272 9-10-epome-d4 Leukotoxin-d4; 9,10-EODE-d4 epoxides epoxygenasse leukotoxin cytochrome P450 (+/-)9(10)-EpOMEs (+/-)9,10-EpOMEs epoxy fatty acids deuterated deuterium 3.026095764272
338420 9-OxoODE-d3 - ≥99% deuterated forms (d1- d3) 2011-11-11 7.530257826887 9-oxoode-d3 9-KODE-d3 9-KODEs metabolites oxo-acids metabolites fatty 9-OxoODEs 9-oxo-ODEs deuterateds deuterium mass spectrometry LC-MS LC/MS reticulocyte mitochondrial plasma membranes lipids LC MS 15-LO OxoODEs 15-lipoxygenase linoleate residues acids oxo-fatty 7.530257826887
338410 9(S)-HODE-d4 - ≥99% deuterated forms (d1- d4) 20.920441988950 9-s-hode-d4 GC/MS deuterium isotopes 9-HODE-d4 standards 9S-HODE-d4 deuterated GC-MS LC/MS LC-MS 9-HODEs 9(S)-HODEs 9S-HODEs 9(S)HODES hydroxy fatty acids 9(S)HODE-d4 mass spectrometry 20.920441988950
10706 AM2201-d5 Exclusive - ≥99% deuterated forms (d1- d5) ✓ 2011-05-16 53.678816923285 am2201-d5 cannabinoids CB1 CB2 receptors pain forensic sciences CBs AM2201 AM-2201 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry standards 53.678816923285
11457 AM2201 N-(4-hydroxypentyl) metabolite-d5 Exclusive New - ≥99% deuterated forms (d1-d5) ✓ 2012-03-13 109.116260245029 am2201-n-4-hydroxypentyl-metabolite-d5 cannabinoids central peripheral metabolites CB1 CB2 receptors pain forensic sciences synthetics smoking urinary urine potent CBs AM2201 AM-2201 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry standards 109.116260245029
390010 Arachidonic Acid-d8 69254-37-1 ≥99% deuterated forms (d1-d8) 209.218998618785 arachidonic-acid-d8 standards AA-d8 deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated fatty acids PUFAs polyunsaturated 209.218998618785
10007277 Arachidonic Acid-d8 Lipid Maps MS Standard 69254-37-1 ≥99% deuterated forms (d1-d8) 2009-03-02 84.566885359116 arachidonic-acid-d8-lipid-maps-ms-standard standards AA-d8 deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated fatty acids PUFAs polyunsaturated 84.566885359116
10011178 Arachidonoyl Ethanolamide-d4 946524-40-9 ≥99% deuterated forms (d1-d4) 2008-03-04 40.586823204420 arachidonoyl-ethanolamide-d4 AEA-d4; Anandamide-d4 deuterium GC/MS internal isotopes standards ethanolamides LC/MS mass spectrometry cannabinoids fatty acids deuterated neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic 40.586823204420
390050 Arachidonoyl Ethanolamide-d8 - ≥99% deuterated forms (d1-d8) 42.214751381215 arachidonoyl-ethanolamide-d8 Anandamide-d8; AEA-d8 deuterium GC/MS internal isotopes standards ethanolamides GC-MS LC/MS LC-MS mass spectrometry cannabinoids deuterated fatty acids neurochemistry neuroscience ethanolamines endocrinology 42.214751381215
9000528 Bromoenol lactone-d7 - ≥99% deuterated forms (d1-d7) 2010-06-21 15.601223362273 bromoenol-lactone-d7 Haloenol lactone-d7; HELSS-d7; BEL-d7 selective iPLA2 inhibitors phospholipases PLAs deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS inhibited inhibition 15.601223362273
10009523 CAY10429-d3 - ≥99% deuterated forms (d1-d3) 2007-10-02 4.785082872929 cay10429-d3 Abnormal Cannabidiol-d3; Abn-CBD-d3 endocannabinoids cannabidiols abnormal abn-cbd non-CB1 non-CB2 receptors agonists BV-2 microglials hypotensives GPCR neurochemistry neurosciences cannabindoids CB1 CB2 deuterated deuterium mass spectrometry LC-MS GC-MS AbnCBD LC/MS GC/MS cannabinoids cbs synthetic 4.785082872929
10010688 Ceftiofur-d3 - ≥99% deuterated product 2011-10-13 0E-12 ceftiofur-d3 80370-57-6 standards isotopically pharmaceutical cephalosporin antibiotic cattle swine bacterial infections respiratory tract deuterated deuterium 0E-12
9000595 CEP-Lysine-d4 Exclusive - ≥99% deuterated forms (d1-d4) ✓ 2010-08-23 31.147900552486 cep-lysine-d4 Docosahexaenoic acid DHA oxidative stress 2-(ω-carboxyethyl)pyrrole CEP carboxyethylpyrrole advanced glycation end products biomarkers age-related macular degeneration deuterateds internal standard GC LC chromatography mass spectrometry GC-MS LC-MS GC/MS LC/MS deuterium 31.147900552486
10686 (±)-CP 47,497-C8-homolog-d7 (solution) Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-03-14 25.726973152059 -cp-47-497-c8-homolog-d7-solution Cannabicyclohexanol-d7 cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS GC LC standards stds 10914 25.726973152059
10687 (±)-CP 47,497-d11 (solution) Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2011-02-16 34.319074410242 -cp-47-497-d11-solution receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 10907 34.319074410242
10458 Dihomo-γ-Linolenic Acid-d6 Exclusive - ≥99% deuterated forms (d1-d6) ✓ 2011-06-13 13.281111111111 dihomo-linolenic-acid-d6 DGLA-d6 deuterated LC/MS GC-MS LC-MS mass spectrometry polyunsaturated dihomo-g-linolenic dihomo-γ-linolenic dihomo-gamma-linolenic omega-6 ω-6 fatty acids antagonists arachidonic receptors LTB4 deuterium 13.281111111111
10696 dinor-12-oxo Phytodienoic Acid-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2011-04-04 35.514116914182 dinor-12-oxo-phytodienoic-acid-d5 dinor-12-oxo PDA-d5; dinor-OPDA-d5 jasmonates pathways plants hormones senescence development intermediates jasmonic acids glycerolipids galactolipids arabidopsides dnOPDA dn-OPDA deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS LC GC standards 35.514116914182
11219 DMABA-d10 NHS ester New 1175002-05-7 9% deuterated forms (d1-d10) 2012-02-15 0E-12 dmaba-d10-nhs-ester GC/MS deuterium deuterateds internal standards LC/MS GC-MS LC-MS mass spectrometry MS phosphatidylethanolamines FAAH fatty acids synthesis PUFA polyunsaturated fatty acyl phospholipids probes electorspray tandem PE lipids markers 0E-12
11217 DMABA-d4 NHS ester New 1175002-03-5 ≥99% deuterated forms (d1-d4) 2012-02-15 0E-12 dmaba-d4-nhs-ester DMABA N-hydroxysuccinimide ester-d4; N-Succinimidyl 4-(dimethylamino)benzoate-d4; 4-(dimethylamino) Benzoic Acid-d4 GC/MS deuterium deuterateds internal standards LC/MS GC-MS LC-MS mass spectrometry MS phosphatidylethanolamines FAAH fatty acids synthesis PUFA polyunsaturated fatty acyl phospholipids probes electorspray tandem PE lipids markers 0E-12
11218 DMABA-d6 NHS ester New 1175002-04-6 ≥99% deuterated form (d1-d6) 2012-02-07 0E-12 dmaba-d6-nhs-ester DMABA N-hydroxysuccinimide ester-d6; 4-(dimethylamino) Benzoic Acid-d6; N-Succinimidyl 4-(dimethylamino)benzoate-d6 GC/MS deuterium deuterateds internal standards LC/MS GC-MS LC-MS mass spectrometry MS phosphatidylethanolamines FAAH fatty acids synthesis PUFA polyunsaturated fatty acyl phospholipids probes electorspray tandem PE lipids markers 0E-12
10005057 Docosahexaenoic Acid-d5 - ≥99% deuterated forms (d1-d5) 2005-03-16 218.188360957642 docosahexaenoic-acid-d5 Cervonic Acid-d5; DHA-d5 standards deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 retinol neuronal membranes neonatal deprivation hypertension 218.188360957642
9001108 Docosahexaenoyl Ethanolamide-d4 Exclusive New 946524-43-2 ≥99% deuterated forms (d1-d4) ✓ 2012-02-21 19.810945429872 docosahexaenoyl-ethanolamide-d4 DHEA-d4; DEA-d4 neurochemistry neuroscience endocannabinoids brain retina docosahexaenoic acids DHA fatty w-3 .omega.-3 neural tissues ethanolamines ethanolamides arachidonoyl AEA lipids extracts piglets diets rats CB1 receptors shaker-related voltage-gated potassium channels cannabinoids cbs synthetic DEA deuterateds deuteriums LC-MS GC/MS GC-MS mass spectrometry LC/MS MS 19.810945429872
10005056 Eicosapentaenoic Acid-d5 145191-14-6 ≥99% deuterated forms (d1-d5) 2005-08-30 291.556055248619 eicosapentaenoic-acid-d5 EPA-d5; Timnodonic Acid-d5 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 inflammation analogs marine organisms coronary heart diseases thrombosis ischemic brain injury scaly dermatitis inflammatory 291.556055248619
10919 (±)-epi CP 47, 497 - ≥98% 2011-05-05 9.598423751790 -epi-cp-47-497 3-trans CP 47,497 (±)-trans-CP 47,497 cannabinoids analogs receptors CB1 standards (±)-CP47,497 analgesic potency epimer THC .delta.-THC (±)-iso Δ-tetrahydrocannabidiol CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 13801 9.598423751790
13801 (±)-epi CP 47,497 (solution) Exclusive - ≥98% ✓ 2010-08-04 9.334116612362 -epi-cp-47-497-solution 3-trans CP 47,497 (±)-trans-CP 47,497 cannabinoids analogs receptors CB1 standards (±)-CP47,497 analgesic potency epimer THC .delta.-THC (±)-iso Δ-tetrahydrocannabidiol CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 10919 9.334116612362
10570 Heneicosapentaenoic Acid-d6 - ≥99% deuterated forms (d1-d6) 2010-12-13 37.391514903485 heneicosapentaenoic-acid-d6 24257-10-1 c21:5 C-21:5 C 21:5 omega-3 .omega.-3 w-3 deterateds deuteriums standards mass spectrometry LC/MS GC/MS LC-MS GC-MS MS 37.391514903485
11622 Heneicosapentaenoic Acid methyl ester Exclusive New 65919-53-1 ≥98% ✓ 2012-04-23 101.111111111110 heneicosapentaenoic-acid-methyl-ester HPA methyl ester fatty acids EPA DHA arachidonic linoleic PGH synthases 5-LO prodrugs 5-LOX LO LOX prostaglandins PGs HPA Bryopsis pennata Lamouroux green algae fish oils eicosapentaenoic docosahexaenoic phospholipids 5-lipoxygenases 5 lipoxygenases 101.111111111110
316300 iPF2α-VI-d4 214977-79-4 ≥99% deuterated forms (d1-d4) 39.123701657458 ipf2-vi-d4 8-iso-5(R),6E,14Z-Prostaglandin F2α-d4 deuteriums isotopes 8-isoprostanes iPF2.alpha.-VI-d4 iPF2alpha-VI-d4 lipid peroxidation oxidative ipf2a injury stress prostaglandins deuterated iPF2a-VI-d4 pgf2a deuterium GC/MS GC-MS LC/MS LC-MS mass specrometry 39.123701657458
10486 JWH 007-d9 - ≥99% deuterated forms (d1-d9) 2010-10-11 38.180851749539 jwh-007-d9 agonists cannabinoids receptors CB1 CB2 Δ9-THC pain antinociception hypothermia catalepsy deuterateds deuteriums mass spectrometry MS standards JWHs JWH007-d9 JWH-007-d9 cannabinoids cbs synthetic JWH7-d9 JWH 7-d9 JWH-7-d9 38.180851749539
10660 JWH 015-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-02-21 44.219281767956 jwh-015-d7 agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-γ IFN-gamma CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 cannabinoids cbs synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry deuteriums deuterateds standards JWH15-d7 JWH 15-d7 JWH-15-d7 44.219281767956
10711 JWH 018 2-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated forms (d1-d9) ✓ 2011-02-25 12.710481456396 jwh-018-2-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs monohydroxylated standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 12.710481456396
10712 JWH 018 4-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated forms (d1-d9) ✓ 2011-02-25 15.974211548210 jwh-018-4-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 15.974211548210
10713 JWH 018 5-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated forms (d1-d9) ✓ 2011-03-11 16.057740414512 jwh-018-5-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards M-2 M2 JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 16.057740414512
10714 JWH 018 6-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated forms (d1-d9) ✓ 2011-03-25 29.737593084863 jwh-018-6-hydroxyindole-metabolite-d9 cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 29.737593084863
10715 JWH 018 7-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated forms (d1-d9) ✓ 2011-07-26 8.456755434286 jwh-018-7-hydroxyindole-metabolite-d9 WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 smoking mixture spices synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 CBs cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic sciences pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 4 M4 M-4 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 8.456755434286
13824 JWH 018-d9 (solution) - ≥99% deuterated forms (d1-d9) 2010-06-21 48.264956879881 jwh-018-d9-solution cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cbs synthetic JWH018-d9 JWH-018-d9 JWH-18-d9 JWH 18-d9 JWH18-d9 JWH18d9 10901 48.264956879881
10926 (±)-JWH 018 N-(4-hydroxypentyl) metabolite-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2011-06-28 48.189223825681 -jwh-018-n-4-hydroxypentyl-metabolite-d5 JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabinoids WIN 55,212-2 urinary metabolites forensics CBs WIN 55212-2 WIN55,212-2 WIN55212-2 monohydroxylation metabolism N-alkyl chains agonists peripheral central receptors smoking mixtures GC/MS deuteriums standards deuterateds LC/MS GC-MS LC-MS mass spectrometry 48.189223825681
10933 JWH 018 N-(5-hydroxypentyl) metabolite-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2011-06-22 65.383411098240 jwh-018-n-5-hydroxypentyl-metabolite-d5 cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBs M-5 M5 synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 bath salts LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums agonists selective M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 65.383411098240
9000867 JWH 018 N-pentanoic acid metabolite-d4 Exclusive - ≥99% deuterated forms (d1-d4) ✓ 2010-09-15 231.759091679792 jwh-018-n-pentanoic-acid-metabolite-d4 JWH-018 JWH018 deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices synthetic M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 231.759091679792
10716 JWH 073 2-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-03-10 13.307377506650 jwh-073-2-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites monohydroxylated forensics JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 glucuroconjugate JWH-073 JWH073 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 13.307377506650
10717 JWH 073 4-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-02-21 6.044669013027 jwh-073-4-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 6.044669013027
10718 JWH 073 5-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-03-11 10.114667254961 jwh-073-5-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics Metabolite 2 JWH-073 JWH073 M-2 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 10.114667254961
10719 JWH 073 6-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-03-11 5.957007871222 jwh-073-6-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 5.957007871222
10720 JWH 073 7-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-07-25 2.962005138349 jwh-073-7-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics CBs deuterateds deuterium mass spectrometry MS LC/MS LC-MS GC-MS GC/MS WIN55212-2 WIN552122 pain neuroscience JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 2.962005138349
9000868 JWH 073-d7 (solution) Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2010-08-10 34.439604184391 jwh-073-d7-solution deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-073 JWHs JWH073 JWH73 JWH-73 JWH 73 cannabinoids CB1 receptors CB2 peripheral central cbs synthetic JWH073d7 JWH-073-d7 JWH073-d7 JWH73-d7 JWH-73-d7 JWH73-d7 JWH73d7 10905 34.439604184391
10927 (±)-JWH 073 N-(3-hydroxybutyl) metabolite-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2011-07-25 34.000722142645 -jwh-073-n-3-hydroxybutyl-metabolite-d5 deuterateds deuterium GC-MS GC/MS LC-MS LC/MS mass spectrometry MS JWH073 JWH73 JWH-073 JWH-73 cannabinoids metabolites cannabimimetic aminoalkyl chains adulterant CBs metabolism in vitro smoking mixtures pain neuroscience 34.000722142645
9000870 JWH 073 N-butanoic acid metabolite-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2010-09-20 81.275709907057 jwh-073-n-butanoic-acid-metabolite-d5 JWH 073 Metabolite 6-d5 JWH-073 JWH073 cannabinoids CBs receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 deuterateds deuteriums mass spec GC-MS LC-MS GC/MS LC/MS M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 81.275709907057
10511 JWH 081-d9 - ≥99% deuterated forms (d1-d9) 2011-09-08 34.895498379446 jwh-081-d9 cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine forensics endocannabinoids indoles central peripheral receptors cannabinoids CBs synthetic JWH-081 JWH 81 JWH-81 JWH81 standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 34.895498379446
10512 JWH 122-d9 - ≥99% deuterated forms (d1-d9) 2011-09-08 82.701417264663 jwh-122-d9 JWHs JWH-122 JWH122 cannabinoids CB1 CB2 CBs CB-1 CB-2 receptors potent synthetic forensics pain central peripheral cannabinoids CBs synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 82.701417264663
11475 JWH 122 N-(5-hydroxypentyl) metabolite-d5 Exclusive New - ≥99% deuterated forms (d1-d5) ✓ 2012-04-27 177.815253720284 jwh-122-n-5-hydroxypentyl-metabolite-d5 MAM2201 N-(5-hydroxypentyl) metabolite-d5 LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cannabinoids cbs synthetic receptors CB1 CB2 cannabimimetics analogs forensics JWH122 JWH-122 monohydroxylation N-alkyl chains naphthoylindole JWH 018 JWH018 JWH-018 JWH18 JWH-18 JWH 18 JWH073 JWH-073 JWH 073 JWH73 JWH-73 JWH 73 177.815253720284
10903 JWH 200-d5 - ≥99% deuterated forms (d1-d5) 2011-05-06 7.401256906077 jwh-200-d5 cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-200-d5 JWH200-d5 10903 7.401256906077
10682 JWH 200-d5 (solution) - ≥99% deuterated forms (d1-d5) 2011-01-07 35.027270718231 jwh-200-d5-solution cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-200-d5 JWH200-d5 10903 35.027270718231
10510 JWH 210-d9 - ≥99% deuterated forms (d1-d9) 2011-09-08 28.281393228426 jwh-210-d9 cannabimimetic cannabinoids alklyindoles CB1 CB2 receptors agonists CBs JWH-210 JWH210 JWHs standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS pain 28.281393228426
10661 JWH 250-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2011-02-14 37.389532481263 jwh-250-d5 cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-250-d5 JWH250-d5 37.389532481263
11474 JWH 250 N-(5-hydroxypentyl) metabolite-d5 Exclusive New - ≥99% deuterated forms (d1-d5) ✓ 2012-04-27 122.875777105692 jwh-250-n-5-hydroxypentyl-metabolite-d5 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS synthetic JWH250 JWH-250 forensic sciences CBs cannabinoids JWHs cannabimimetics metabolites CB1 CB2 receptors agonists spices forensics synthetics smoking urinary urine serum JWH-18 JWH 18 JWH18 JWH018 JWH-018 JWH 018 JWH 15 JWH-15 JWH15 JWH015 JWH-015 JWH 015 122.875777105692
10514 JWH 398-d9 Exclusive - ≥99% deuterated forms (d1-d9) ✓ 2011-08-25 38.562490444706 jwh-398-d9 JWH398 JWH-398 standards cannabinoids CBs JWHs forensics sciences deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 38.562490444706
316811 Latanoprost (free acid)-d4 - ≥99% deuterated forms (d1-d4) 70.356774861878 latanoprost-free-acid-d4 PhXA 85-d4; 17-phenyl-13,14-dihydro trinor Prostaglandin F2α-d4; Lat-FA-d4 eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular acids GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry 17-phenyl-13,14-dihydro-trinor-PGF2.alpha.-d4 PhXA85-d4 17-phenyl-13,14-dihydro-trinor-PGF2alpha-d5 LatFA-d4 17-phenyl-13,14-dihydro trinor-PGF2a-d4 70.356774861878
320110 Leukotriene B4-d4 - ≥99% deuterated forms (d1-d4) 143.486187845304 leukotriene-b4-d4 LTB4-d4 GC/MS LTB4-d4 deuterium internal standards isotopes leukotrienes GC-MS mass spectrometry LC/MS LC-MS deuterated spectroscopy atherosclerosis mass spectrometry 143.486187845304
10007240 Leukotriene B4 Lipid Maps MS Standard 71160-24-2 ≥97% 2009-01-14 29.751524861878 leukotriene-b4-lipid-maps-ms-standard LTB4 leukotrienes LTB4 inflammation chemotaxis atherosclerosis LTs MS mass spectrometry standards 29.751524861878
10006198 Leukotriene C4-d5 - ≥99% deuterated forms (d1-d5) 2007-04-11 154.699889502763 leukotriene-c4-d5 LTC4-d5 cysteinyl-leukotrienes LTC4 asthma SRS-A slow-reacting substance anaphylaxis allergy peptido-leukotrienes cysteinyl-LTs peptido-LTs cys-LTs GC/MS deuterium isotopes LTC4-d5 internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry 154.699889502763
10007241 Leukotriene C4 Lipid Maps MS Standard 72025-60-6 >97% 2009-01-07 45.879165131982 leukotriene-c4-lipid-maps-ms-standard LTC4 cysteinyl-leukotrienes LTC4 asthma SRS-A slow-reacting substance anaphylaxis allergy peptido-leukotrienes cysteinyl-LTs peptido-LTs cys-LTs MS mass spectrometry standards asthma cyslts 45.879165131982
10006199 Leukotriene D4-d5 - ≥99% deuterated forms (d1-d5) 2008-04-23 52.451625887924 leukotriene-d4-d5 LTD4-d5 peptido-leukotrienes LTD4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes deuterated deuterium cysLTs GC/MS GC-MS LC/MS LC-MS mass spectrometry 52.451625887924
10007858 Leukotriene E4-d5 - ≥99% deuterated forms (d1-d5) 2008-04-08 110.897298956415 leukotriene-e4-d5 LTE4-D5 peptido-leukotrienes LTE4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes deuterated deuterium cysLTs GC/MS GC-MS LC/MS LC-MS mass spectrometry 110.897298956415
10007242 Leukotriene E4 Lipid Maps MS Standard 75715-89-8 >97% 2009-01-06 56.993003157064 leukotriene-e4-lipid-maps-ms-standard LTE4 peptido-leukotrienes LTE4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes LTs MS mass spectrometry standards 56.993003157064
390150 Linoleic Acid-d4 Exclusive 79050-23-0 ≥99% deuterated forms (d1-d4) ✓ 9.927914364641 linoleic-acid-d4 standards deuterated deuterium GC/MS internal isotopes GC-MS LC/MS LC-MS mass spectrometry fatty acids 9.927914364641
9000553 Linoleoyl Ethanolamide-d4 Exclusive - ≥99% deuterated forms (d1-d4) ✓ 2010-01-13 2.351657458564 linoleoyl-ethanolamide-d4 cannabinoids neurotransmitter ethanolamides fatty acids neurochemistry neuroscience ethanolamines linoleyl deuterateds deuteriums LC-MS GC/MS GC-MS mass spectrometry standards LC/MS MS cbs synthetic 2.351657458564
10010228 Lyso-PAF C-18 -d4 Exclusive - ≥99% deuterated forms (d1-d4) ✓ 2010-11-03 18.899071823204 lyso-paf-c-18-d4 PAFs platelet-activating factors deuterateds deuterium mass spectrometry MS LC/MS GC/MS LC-MS GC-MS 18.899071823204
9001141 Meconin-d3 New - ≥99% deuterated forms (d1-d3) 2012-02-29 81.657179224372 meconin-d3 Opianyl-d3; NSC 35547-d3 meconine opium heroin urinary urine metabolites forensics science opiates NSC-35547 NSC35547 oplanyl EINECS 209-311-8 6,7-dimethoxyphthalide maconine mekonin lactones deuterateds deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS 81.657179224372
10624 Methylenedioxy Pyrovalerone Exclusive 687603-66-3 ≥98% ✓ 2011-01-07 31.370797503581 methylenedioxy-pyrovalerone MDPV 3,4-methylenedioxypyrovalerone inhibitors neurotransmitters dopamine norepinephrine MDMA ecstasy forensics designer drugs Hemihydrate Apomorphine Hydrochloride Anhydrous Apomorphine Hydrochloride Chloride Apomorphine Apomorphin Teclapharm Apomorphine Chloride Berberine Alkaloids Camptothecine Camptothecin Umbellatine Apomorphine Britaject Berberine Alkaloids Berbines Apokinon 31.370797503581
10679 Methylenedioxy Pyrovalerone-d8 (hydrochloride) 1246820-09-6 ≥99% deuterated product 2011-02-15 24.109879362481 methylenedioxy-pyrovalerone-d8-hydrochloride MDPV-d8 3,4-methylenedioxypyrovalerone inhibitors neurotransmitters dopamine norepinephrine MDMA ecstasy neuroscience forensics designer drugs deuterateds deuteriums GC/MS GC-MS LC/MS LC-MS mass spectrometry MS standards 24.109879362481
9001143 Norsufentanil-d3 Exclusive New 1204688-16-3 ≥99% deuterated forms (d1-d3) ✓ 2012-04-27 161.351168073780 norsufentanil-d3 R 30451-d3 deuterateds deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS noralfentanil R30451 R-30451 opioids metabolites forensics cytochromes P450 CYP450 pain anesthesia synthetics sufentanil livers isoforms P-450 P 450 161.351168073780
9000432 Oleic Acid-d17 - ≥99% deuterated forms (d1-d17) 2010-08-30 3.727113259668 oleic-acid-d17 deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated fatty acids monounsaturated 9Z-octadecenoic Acid cis-9-Octadecenoic Oleic Acids 12-hydroxy Oleic Acids, 12 hydroxy cis-9-Octadecenoic Acid cis 9 Octadecenoic Acid Acids, 12-hydroxy Oleic 12-hydroxy Oleic Acids Acid 9-Octadecenoic Acids Octadecenoic 9-Octadecenoic Acid 9 Octadecenoic Acid Octadecenoic Acids Acids Ricinoleic Ricinoleic Acids Acids Oleic Oleic Acids Acid Oleic Oleic Acid Oleate 3.727113259668
10007823 Oleoyl Ethanolamide-d2 - ≥99% deuterated forms (d1-d2) 2006-03-06 17.913535911602 oleoyl-ethanolamide-d2 OEA-d2; Oleic Acid Ethanolamide-d2 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides cbs synthetic 17.913535911602
9000552 Oleoyl Ethanolamide-d4 Exclusive - ≥99% deuterated forms (d1- d4) ✓ 2010-01-12 10.248737174428 oleoyl-ethanolamide-d4 Oleic Acid Ethanolamide-d4; OEA-d4 cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides deuterateds deuteriums MS mass spectrometry CBs LC-MS OEAs LC/MS GC/MS G-MS standards PPAR brain tissue neurochemistry neuroscience synthetic 10.248737174428
9000694 Oleoyl Serotonin-d17 Exclusive - ≥99% deuterated forms (d1-d17) ✓ 2010-09-27 6.470165745857 oleoyl-serotonin-d17 N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA deuterateds deuteriums MS mass spectrometry GC-MS LC-MS GC/MS LC/MS standards 6.470165745857
10010229 PAF C-18-d4 Exclusive - ≥99% deuterated forms (d1-d4) ✓ 2010-11-03 18.859116022099 paf-c-18-d4 PAFs platelet-activating factors atherosclerosis deuterateds deuterium mass spectrometry MS LC/MS GC/MS LC-MS GC-MS 18.859116022099
10007824 Palmitoyl Ethanolamide-d4 Exclusive 1159908-45-8 ≥99% deuterated forms (d1-d4) ✓ 2006-03-06 12.649668508287 palmitoyl-ethanolamide-d4 Palmidrol-d4; PEA-7,7,8,8-d4 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cyclic cAMP ethanolamides anandamides AEA fatty acids neurochemistry ethanolamines cannabinoids cbs synthetic 12.649668508287
9000746 Pentylone (hydrochloride) 17763-01-8 ≥98% 2011-04-20 69.778877351744 pentylone-hydrochloride mephedrone MDMA ecstasy neuroscience forensics designer drugs MDPV valerophenone 1-pentanone pentanone 698963-77-8 69.778877351744
11344 PGDM-d4 New - ≥99% deuterated forms (d1-d4) 2012-02-02 35.913067166651 pgdm-d4 Prostaglandin D Metabolite-d4 PGD-M deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry urine PGD2 prostaglandins D2 PGs metabolites urinary side chains cyclization biomarkers endogenous allergic asthmatic sleep body temperatures 35.913067166651
312010 Prostaglandin D2-d4 - ≥99% deuterated forms (d1-d4) 52.674930939227 prostaglandin-d2-d4 PGD2-d4 GC/MS deuterium isotopes PGD2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience 52.674930939227
10010123 Prostaglandin D2-d9 - ≥99% deuterated forms (d1-d9) 2007-10-25 46.889442425124 prostaglandin-d2-d9 PGD2-d9 GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience allergy asthma 46.889442425124
10007202 Prostaglandin D2 Lipid Maps MS Standard 41598-07-6 >99% 2008-10-27 15.401542711432 prostaglandin-d2-lipid-maps-ms-standard PGD2 Vasodilation prostaglandins brain sleep platelets aggregation. H-PGDS synthases mast cells hematopoietic allergic allergy asthmatic anaphylaxis hypotension inhibits inhibitors inhibition beta-trace .beta.-trace b-trace neurochemistry mass spectrometry standards GC LC MS 15.401542711432
313010 Prostaglandin E1-d4 - ≥99% deuterated forms (d1-d4) 26.785285451197 prostaglandin-e1-d4 Alprostadil-d4; PGE1-d4 GC/MS deuterium isotopes PGE1-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry atherosclerosis 26.785285451197
314010 Prostaglandin E2-d4 - ≥99% deuterated forms (d1-d4) 105.329093922652 prostaglandin-e2-d4 Dinoprostone-d4; PGE2-d4 GC/MS deuterium isotopes PGE2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry 105.329093922652
10581 Prostaglandin E2-d9 - ≥99% deuterated forms (d1-d9) 2010-09-16 96.365778084715 prostaglandin-e2-d9 PGE2-d9; Dinoprostone-d9 PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins pharma:2 deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards 96.365778084715
316010 Prostaglandin F2α-d4 34210-11-2 ≥99% deuterated forms (d1- d4) 27.816883977900 prostaglandin-f2-d4 Dinoprost-d4; PGF2α-d4 GC/MS deuterium isotopes PGF2a-d4 PGF2alpha-d4 PGF2.alpha.-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry prostaglandin f2a d4 27.816883977900
10008643 Prostaglandin F2α-d9 - ≥99% deuterated forms (d1-d9) 2006-08-04 29.466616942909 prostaglandin-f2-d9 Dinoprost-d9 GC/MS deuterium PGF2.alpha.-d9 PGF2alpha-d9 internal standards prostaglandins mass spectrometry LC/MS GC-MS LC-MS deuterated PGF2a-d9 29.466616942909
10007221 Prostaglandin F2α Lipid Maps MS Standard 551-11-1 >99% 2008-12-13 50.676303867403 prostaglandin-f2-lipid-maps-ms-standard PGF2α; Dinoprost PGF2alpha PGF2.alpha. Lutalyse vasoconstriction bronchoconstriction prostaglandins endocrinology prostaglandin f2alpha f2 alpha MS Mass Spectrometry 50.676303867403
10005615 PtdIns-(4,5)-P2 (1,2-dipamitoyl)-d62 (sodium salt) - ≥99% deuterated product 2006-01-30 15.227603059923 ptdins-4-5-p2-1-2-dipamitoyl-d62-sodium-salt Phosphatidylinositol-4,5-diphosphate C16-d62; DPPI-4,5-P2-d62 phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated diacyl glycerols DAG PIP2 triphosphates mono di 15.227603059923
10513 RCS-4-d9 - ≥99% deuterated product 2011-09-12 34.954514656230 rcs-4-d9 cannabinoids receptors JWHs 018 CB1 CB2 cannabimimetics forensics sciences CBs neurochemistry synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 34.954514656230
10009039 tetranor-PGDM-d6 Exclusive - ≥99% deuterated product ✓ 2007-06-28 47.891203449603 tetranor-pgdm-d6 tetranor-Prostaglandin D Metabolite-d6 deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry PGD-M t-PGDM t-prostaglandin 47.891203449603
314840 tetranor-PGEM-d6 Exclusive - ≥99% deuterated product ✓ 70.477634816798 tetranor-pgem-d6 tetranor-Prostaglandin E Metabolite-d6 GC/MS deuterium isotopes tetranor-PGEM-d6 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry metabolites urinary markers PGE-M t-PGEM t-prostaglandin 70.477634816798
10007216 tetranor-PGEM Lipid Maps MS Standard 24769-56-0 ≥98% 2008-12-13 54.427292817679 tetranor-pgem-lipid-maps-ms-standard tetranor-Prostaglandin E Metabolite metabolites urinary markers PGE1 PGE2 urine metabolites MS mass spectrometry standards PGE-M t-PGEM t-prostaglandin 54.427292817679
10007228 tetranor-PGFM Lipid Maps MS Standard 23109-94-6 >98% 2008-12-18 22.958591160221 tetranor-pgfm-lipid-maps-ms-standard tetranor-Prostaglandin F Metabolite metabolites PGF2alpha PGF2.alpha. urinary urine markers PGF2α MS mass spectrometry standards PGF-M t-PGFM t-prostaglandin 22.958591160221
319030 Thromboxane B2-d4 - ≥99% deuterated product 44.321860036832 thromboxane-b2-d4 TXB2-d4 GC/MS deuterium isotopes internal standards GC-MS LC/MS LC-MS mass spectrometry atherosclerosis prostaglandins TXB2-d4 thromboxanes deuterated 44.321860036832
13130 trans-Resveratrol-d4 - ≥99% deuterated product 2009-01-14 20.881717311234 trans-resveratrol-d4 (E)-Resveratrol-d4 selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis deuterated LC/MS GC-MS LC-MS mass spectrometry deuterium sirtuins AHR antagonists aryl hydrocarbon receptors 20.881717311234
9000433 α-Linolenic Acid-d14 - ≥99% deuterated forms (d1-d14) 2010-09-13 8.445831798649 -linolenic-acid-d14 ALA-d14 fatty acids PUFAs omega-3 ω-3 polyunsaturated essential leafy green vegetables deuterium deuterateds GC/MS GC-MS LC/MS LC-MS mass spectrometry MS signalling standards alpha-linolenic α-linolenic signaling ALAS α-linolenic 8.445831798649
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?